Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients across the globe, and Japanese pharmaceutical company Fuji Pharma Co. Ltd, have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new undisclosed biosimilar candidate.
